Healthcare utilization and spending by children with cancer on Medicaid

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26569. Epub 2017 Apr 18.

Abstract

Background: Children with cancer are a unique patient population with high resource, complex healthcare needs. Understanding their healthcare utilization could highlight areas for care optimization.

Procedure: We performed a retrospective, cross-sectional analysis of the 2014 Truven Marketscan Medicaid Database to explore clinical attributes, utilization, and spending among children with cancer who were Medicaid enrollees. Eligible patients included children (ages 0-18 years) with cancer (Clinical Risk Group 8). Healthcare utilization and spending (per member per month, PMPM) were assessed overall and across specific healthcare services.

Results: Children with cancer (n = 5,405) represent less than 1% of the 1,516,457 children with medical complexity in the dataset. Children with cancer had high services use: laboratory/radiographic testing (93.0%), outpatient specialty care (83.4%), outpatient therapy/treatment (53.4%), emergency department (43.7%), hospitalization (31.5%), home healthcare (9.5%). PMPM spending for children with cancer was $3,706 overall and $2,323 for hospital care.

Conclusion: Children with cancer have high healthcare resource use and spending. Differences in geographic distribution of services for children with cancer and the trajectory of spending over the course of therapy are areas for future investigation aimed at lowering costs of care without compromising on health outcomes.

Keywords: outcomes research; pediatric oncology; supportive care.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Health Expenditures / statistics & numerical data*
  • Health Services / economics
  • Health Services / statistics & numerical data*
  • Hospitalization
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Medicaid / economics*
  • Medicaid / statistics & numerical data
  • Neoplasms / economics*
  • Neoplasms / therapy*
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Prognosis
  • Retrospective Studies
  • United States